At What Cost?
An Atlantic Forum on Prescription Drugs

October 3, 2017
Washington, DC

A new era of prescription drugs has seen record numbers of FDA approved drugs enter the market, helping millions fight disease. At the same time, drug prices are soaring, and debates have resonated from Washington and beyond on how to transform health care and reduce spending.  How can the health care industry work to make prescription drugs more affordable?

The Atlantic convened top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.

Watch full session videos

To view photos from this event, please visit our Facebook page

Presented by

Atlantic Live

Speakers

Agenda

  • Tuesday, October 03
  • 8:10 a.m.WelcomeMargaret Low, President, AtlanticLIVE
  • 8:15 a.m.A View from the SenateSenator Amy Klobuchar (D-MN)
    With Matt Thompson, Executive Editor, The Atlantic
  • 8:40 a.m.Mapping the DebateMatt Eyles, Executive Vice President of Policy and Regulatory Affairs, America’s Health Insurance Plans
    Lori Reilly, Executive Vice President, Policy and Research, PhRMA
    With Matt Thompson, The Atlantic
  • 9:10 a.m.A View from the HouseRepresentative Patrick Meehan (R-PA)
    With Kathleen Koch, Author and Journalist
  • 9:45 a.m.Personalizing PrescriptionsPeter Bach, Director,Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
    Michael Pishvaian, Director, Phase I Clinical Trial Program, Georgetown Lombardi Comprehensive Cancer Center
    Michael Sapienza, Chief Executive Officer, Colon Cancer Alliance
    With Olga Khazan, Staff Writer, The Atlantic
  • 10:15 a.m.Closing ThoughtsMargaret Low, AtlanticLIVE

Underwriter

Upcoming Events

See All Upcoming Events